Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)
USD 1.56
(-0.51%)
USD 1.56
(-0.51%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 3.76 Billion CNY | -32.92% |
| 2022 | 5.61 Billion CNY | 10.28% |
| 2021 | 5.09 Billion CNY | 13.28% |
| 2020 | 4.49 Billion CNY | 10.17% |
| 2019 | 4.08 Billion CNY | 5.15% |
| 2018 | 3.88 Billion CNY | 10.24% |
| 2017 | 3.52 Billion CNY | 10.14% |
| 2016 | 3.19 Billion CNY | 11.1% |
| 2015 | 2.87 Billion CNY | 11.03% |
| 2014 | 2.59 Billion CNY | 17.06% |
| 2013 | 2.21 Billion CNY | 7.83% |
| 2012 | 2.05 Billion CNY | 0.52% |
| 2011 | 2.04 Billion CNY | 40.24% |
| 2010 | 1.45 Billion CNY | 740.12% |
| 2009 | 173.33 Million CNY | 111.43% |
| 2008 | 81.98 Million CNY | 23.7% |
| 2007 | 66.27 Million CNY | -3.54% |
| 2006 | 68.71 Million CNY | 36.0% |
| 2005 | 50.52 Million CNY | -43.67% |
| 2004 | 89.69 Million CNY | -34.33% |
| 2003 | 136.58 Million CNY | 8.53% |
| 2002 | 125.84 Million CNY | -11.82% |
| 2001 | 142.72 Million CNY | -12.03% |
| 2000 | 162.24 Million CNY | 71.83% |
| 1999 | 94.42 Million CNY | 56.86% |
| 1998 | 60.19 Million CNY | 109.84% |
| 1997 | 28.68 Million CNY | 88.61% |
| 1996 | 15.2 Million CNY | -17.1% |
| 1995 | 18.34 Million CNY | -10.93% |
| 1994 | 20.59 Million CNY | 3.67% |
| 1993 | 19.87 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 1.39 Billion CNY | -9.25% |
| 2024 Q3 | 1.11 Billion CNY | -20.53% |
| 2024 Q1 | 1.54 Billion CNY | 5460.51% |
| 2023 FY | 3.76 Billion CNY | -32.92% |
| 2023 Q1 | 1.51 Billion CNY | 88.94% |
| 2023 Q3 | 1.18 Billion CNY | 8.68% |
| 2023 Q2 | 1.09 Billion CNY | -28.04% |
| 2023 Q4 | -28.77 Million CNY | -102.42% |
| 2022 FY | 5.61 Billion CNY | 10.28% |
| 2022 Q4 | 803.24 Million CNY | -28.17% |
| 2022 Q3 | 1.11 Billion CNY | -54.25% |
| 2022 Q2 | 2.44 Billion CNY | 95.41% |
| 2022 Q1 | 1.25 Billion CNY | 105.34% |
| 2021 Q4 | 609.23 Million CNY | -33.52% |
| 2021 Q3 | 916.47 Million CNY | -36.69% |
| 2021 FY | 5.09 Billion CNY | 13.28% |
| 2021 Q1 | 2.12 Billion CNY | 137.09% |
| 2021 Q2 | 1.44 Billion CNY | -31.72% |
| 2020 Q3 | 1.15 Billion CNY | -17.48% |
| 2020 FY | 4.49 Billion CNY | 10.17% |
| 2020 Q1 | 1.03 Billion CNY | 52.21% |
| 2020 Q2 | 1.4 Billion CNY | 35.32% |
| 2020 Q4 | 894.22 Million CNY | -22.86% |
| 2019 Q2 | 1.16 Billion CNY | 2.99% |
| 2019 FY | 4.08 Billion CNY | 5.15% |
| 2019 Q1 | 1.12 Billion CNY | 121.21% |
| 2019 Q3 | 1.11 Billion CNY | -4.09% |
| 2019 Q4 | 682.01 Million CNY | -38.7% |
| 2018 FY | 3.88 Billion CNY | 10.24% |
| 2018 Q2 | 1.01 Billion CNY | -0.66% |
| 2018 Q3 | 1.33 Billion CNY | 32.11% |
| 2018 Q1 | 1.02 Billion CNY | 22.59% |
| 2018 Q4 | 509.17 Million CNY | -61.96% |
| 2017 Q4 | 832.04 Million CNY | 8.98% |
| 2017 Q3 | 763.47 Million CNY | -17.53% |
| 2017 FY | 3.52 Billion CNY | 10.14% |
| 2017 Q1 | 999.38 Million CNY | 35.19% |
| 2017 Q2 | 925.73 Million CNY | -7.37% |
| 2016 Q4 | 739.22 Million CNY | 2.0% |
| 2016 FY | 3.19 Billion CNY | 11.1% |
| 2016 Q1 | 889.4 Million CNY | 27.39% |
| 2016 Q2 | 843.05 Million CNY | -5.21% |
| 2016 Q3 | 724.71 Million CNY | -14.04% |
| 2015 Q4 | 698.16 Million CNY | 8.28% |
| 2015 FY | 2.87 Billion CNY | 11.03% |
| 2015 Q3 | 644.8 Million CNY | -19.47% |
| 2015 Q1 | 733.27 Million CNY | 8.07% |
| 2015 Q2 | 800.74 Million CNY | 9.2% |
| 2014 Q1 | 586.22 Million CNY | 3.71% |
| 2014 FY | 2.59 Billion CNY | 17.06% |
| 2014 Q4 | 678.54 Million CNY | 14.12% |
| 2014 Q3 | 594.58 Million CNY | -18.75% |
| 2014 Q2 | 731.77 Million CNY | 24.83% |
| 2013 FY | 2.21 Billion CNY | 7.83% |
| 2013 Q1 | 625.66 Million CNY | 23.64% |
| 2013 Q2 | 563.94 Million CNY | -9.86% |
| 2013 Q4 | 565.24 Million CNY | 15.81% |
| 2013 Q3 | 488.06 Million CNY | -13.45% |
| 2012 FY | 2.05 Billion CNY | 0.52% |
| 2012 Q4 | 506.03 Million CNY | 26.79% |
| 2012 Q2 | 571.14 Million CNY | -0.94% |
| 2012 Q1 | 576.56 Million CNY | 75.13% |
| 2012 Q3 | 399.12 Million CNY | -30.12% |
| 2011 Q1 | 885 Million CNY | 236.32% |
| 2011 Q2 | 454.6 Million CNY | -48.63% |
| 2011 Q3 | 358.35 Million CNY | -21.17% |
| 2011 Q4 | 329.21 Million CNY | -8.13% |
| 2011 FY | 2.04 Billion CNY | 40.24% |
| 2010 Q1 | 409.26 Million CNY | 859.73% |
| 2010 FY | 1.45 Billion CNY | 740.12% |
| 2010 Q2 | 374.25 Million CNY | -8.55% |
| 2010 Q3 | 349.43 Million CNY | -6.63% |
| 2010 Q4 | 263.13 Million CNY | -24.7% |
| 2009 FY | 173.33 Million CNY | 111.43% |
| 2009 Q4 | 42.64 Million CNY | -29.57% |
| 2009 Q3 | 60.55 Million CNY | 119.57% |
| 2009 Q2 | 27.57 Million CNY | -35.2% |
| 2009 Q1 | 42.56 Million CNY | 1858.13% |
| 2008 Q3 | 34.63 Million CNY | 75.24% |
| 2008 Q1 | 25.4 Million CNY | 374.1% |
| 2008 FY | 81.98 Million CNY | 23.7% |
| 2008 Q2 | 19.76 Million CNY | -22.2% |
| 2008 Q4 | 2.17 Million CNY | -93.72% |
| 2007 Q4 | 5.35 Million CNY | -74.66% |
| 2007 Q3 | 21.14 Million CNY | -8.5% |
| 2007 Q2 | 23.11 Million CNY | -8.31% |
| 2007 FY | 66.27 Million CNY | -3.54% |
| 2007 Q1 | 25.2 Million CNY | 1307.36% |
| 2006 Q4 | -2.08 Million CNY | -111.91% |
| 2006 FY | 68.71 Million CNY | 36.0% |
| 2006 Q1 | 29.99 Million CNY | 225.5% |
| 2006 Q2 | 25.91 Million CNY | -13.6% |
| 2006 Q3 | 17.52 Million CNY | -32.36% |
| 2005 Q4 | -23.9 Million CNY | -203.43% |
| 2005 FY | 50.52 Million CNY | -43.67% |
| 2005 Q1 | 31.84 Million CNY | 226.88% |
| 2005 Q3 | 23.1 Million CNY | 18.7% |
| 2005 Q2 | 19.46 Million CNY | -38.86% |
| 2004 FY | 89.69 Million CNY | -34.33% |
| 2004 Q4 | -25.09 Million CNY | -185.56% |
| 2004 Q1 | 43.48 Million CNY | -3.53% |
| 2004 Q2 | 45.41 Million CNY | 4.45% |
| 2004 Q3 | 29.33 Million CNY | -35.41% |
| 2003 Q3 | 20.23 Million CNY | -60.0% |
| 2003 FY | 136.58 Million CNY | 8.53% |
| 2003 Q4 | 45.07 Million CNY | 122.73% |
| 2003 Q2 | 50.59 Million CNY | 31.28% |
| 2003 Q1 | 38.54 Million CNY | -10.55% |
| 2002 Q3 | 15.22 Million CNY | -57.61% |
| 2002 FY | 125.84 Million CNY | -11.82% |
| 2002 Q1 | 31.62 Million CNY | 0.0% |
| 2002 Q4 | 43.08 Million CNY | 183.06% |
| 2002 Q2 | 35.91 Million CNY | 13.53% |
| 2001 FY | 142.72 Million CNY | -12.03% |
| 2000 FY | 162.24 Million CNY | 71.83% |
| 1999 FY | 94.42 Million CNY | 56.86% |
| 1998 FY | 60.19 Million CNY | 109.84% |
| 1997 FY | 28.68 Million CNY | 88.61% |
| 1996 FY | 15.2 Million CNY | -17.1% |
| 1995 FY | 18.34 Million CNY | -10.93% |
| 1994 FY | 20.59 Million CNY | 3.67% |
| 1993 FY | 19.87 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| China Medicine Corporation | 1.71 Million USD | -219266.015% |
| DH Enchantment Inc. | -156.15 Thousand USD | 2413117.733% |
| Exlites Holdings International, Inc. | -90.49 Thousand USD | 4163957.515% |
| Itonis, Inc. | -38.31 Thousand USD | 9834880.834% |
| One Step Vending Corp. | -27.79 Thousand USD | 13558932.605% |
| MediPal Holdings Corporation | 274.02 Million USD | -1275.055% |
| PD-Rx Pharmaceuticals, Inc. | -98.06 Thousand USD | 3842488.217% |
| Pharmagen, Inc. | -6457.61 USD | 58349854.491% |
| Suzuken Co., Ltd. | 191.71 Billion USD | 98.035% |